Prepping for HRSA Audits

SPONSORED CONTENT

Are you truly ready for a HRSA audit? Today we have two 340B experts, Dennis Killian and Heather Erickson, from CPS Solutions, LLC. (CPS) here to discuss three topics that will help you prepare. CPS has managed 340B Programs for hospitals and health systems since the program’s inception, ensuring compliance with the 340B statute, HRSA guidance,

Read More »

Bridging the primary care gap: The role of in-house pharmacies in today’s healthcare marketplace

Holly Russo, Maxor 340B

SPONSORED CONTENT

Healthcare leaders have a lot on their plates. Today’s healthcare landscape requires health care organizations to compete in attracting and retaining qualified employees, remain up to date on reimbursement changes, select and employ technologies to serve more patients in convenient ways, and adhere to quality standards to serve their communities.

With

Read More »

Unlocking the Value of 340B Consultants: Their Roles and Responsibilities

SPONSORED CONTENT

In the complex landscape of healthcare, the 340B program plays a vital role in ensuring that vulnerable patients with limited financial resources have access to affordable medications. It enables qualified covered entities to maximize their resources and offer a wider range of benefits and services to those in need.

Managing this program efficiently and

Read More »

340B Webinar—State of 340B in 2024: Biggest Developments Expected this Year

SPONSORED CONTENT

Join our webinar for a comprehensive exploration of the current status of the 340B program, featuring a review of major industry trends from 2023 and key developments anticipated for 2024.
We’ll discuss what entities should expect and prepare for in the upcoming year, addressing crucial questions about manufacturer restrictions and potential Congressional actions.

Read More »

Visante’s Top 10 Issues Facing Health System Pharmacy for 2024

SPONSORED CONTENT

 In 2024, pharmacy will play an even more significant and critical role in health systems’ financial and operational performance nationwide. While health systems face daunting challenges, increasing risks, and suffocating regulatory and compliance burdens, high-performing pharmacy organizations are poised to mitigate financial losses and improve operations. We’ve

Read More »

Exploring Key Aspects of the 340B Program

SPONSORED CONTENT

The 340B drug pricing program allows covered entities serving vulnerable patient populations to buy medications at a discount. Since 1987, AIDS Healthcare Foundation has been on the frontline of the HIV response in the United States.  AHF cares for patients regardless of their ability to pay.  For AHF, 340B savings offset the

Read More »

Implementing for Success

SPONSORED CONTENT

After 30 years of serving vulnerable populations, the 340B Drug Pricing Program has grown considerably in scale and complexity. While it is arguably one of the most successful public/private partnerships in healthcare history, 340B is facing policy obstacles and headwinds that can make administering a program more challenging for covered entities than ever.

Read More »

Unlocking Greater 340B Savings

SPONSORED CONTENT

The 340B program serves as a lifeline for many communities, allowing them to provide critical services to vulnerable, underserved patients. But unfortunately, the industry faces a spectrum of challenges, from mounting drug manufacturer restrictions to incomplete referral claims capture, which hinder a covered entity’s ability to optimize their 340B program.

To

Read More »

340B Outlook from Capitol Hill, Federal Courts, and the States

SPONSORED CONTENT

Get the latest developments in the 340B program with some of the most respected experts in the field. Verity Solutions will be hosting this lively panel discussion again where you will get an up-to-the-minute report on hot button topics related to the policy, compliance,

Read More »

Unlocking the TRUE POTENTIAL of 340B

SPONSORED CONTENT

Primary care organizations often view themselves as a “Medical Home” for their patients, focusing on resolving patient health problems through their medical services. However, a significant challenge for providers lies in the inability to monitor and influence a patient’s behavior in the time between medical visits. Surprisingly, pharmacy professional services, designed to address

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report